Nolato AB (NOLA.B) AI Stock Analysis

• Market Cap: $15.49B
• Dividend Yield: 2.65%
• Average Volume (3M): 168.43K
• Price to Earnings (P/E): 21.0
• Beta (1Y): 1.02
• Revenue Growth: 1.67%
• EPS Growth: 55.37%
• Country: SE
• Employees: 5,405
• Sector: Healthcare
• Sector Strength: 43
• Industry: Conglomerates
• EPS (TTM): 0.80
• Shares Outstanding: 241,783,080
• 10 Day Avg. Volume: 153,802
• 30 Day Avg. Volume: 168,432
• PEG Ratio: 0.43
• Price to Book (P/B): 2.54
• Price to Sales (P/S): 1.51
• P/FCF Ratio: 19.68
• Enterprise Value/Market Cap: 1.09
• Enterprise Value/Revenue: 1.74
• Enterprise Value/Gross Profit: 10.15
• Enterprise Value/Ebitda: 12.01
• 1Y Price Target: $62.78
• Price Target Upside: 10.91% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 71 Outperform
• Price Target: kr63.00 ▲(11.31% Upside)

The overall stock score is driven by strong financial performance, characterized by robust revenue growth, a solid balance sheet, and excellent cash flow generation. The technical analysis indicates potential oversold conditions, while the valuation is reasonable with an attractive dividend yield. The absence of earnings call data or corporate events did not influence the score.

Nolato AB Business Overview & Revenue Model

Company Description

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products for medical technology, pharmaceutical, consumer electronics, telecom, automotive, and other industrial sectors in North America, Sweden, Asia, and other Europe region. The company offers consumables and reusable labware for clinical, chemical, forensic, research, and industrial testing laboratories; manufactures pipette tips, deep-well plates, microtubes, and PCR products; assemblies and post-processing services; and products for primary pharmaceutical packaging, as well as for solids, creams, and ophthalmic and customized production solutions. It designs, develops, and produces advanced components, subsystems, and ready-packaged electronics products, such as laser applications and ceramics, fitness trackers, loudspeaker systems, thermostats, webcams, and vaporiser heating products; automotive products; EMI shielding, thermal interface materials, and silicone sealing and damping solutions; and supplies plastic components and assemblies for food processing equipment, such as coffee machines and blenders. The company was formerly known as Nordiska Latexfabriken i Torekov AB and changed its name to Nolato AB (publ) in 1982. Nolato AB (publ) was incorporated in 1938 and is headquartered in Torekov, Sweden.

How the Company Makes Money

Nolato AB generates revenue primarily through the production and sale of polymer-based products across its different business segments, which include Medical Solutions, Integrated Solutions, and Consumer Products. The Medical Solutions segment, which is a significant contributor to its revenue, focuses on manufacturing components and assemblies for the medical device industry, benefiting from long-term contracts and partnerships with major healthcare companies. The Integrated Solutions segment supplies customized solutions for various industrial applications, leveraging its expertise in polymer processing and design. Additionally, the Consumer Products segment provides products for personal care and hygiene markets. The company's revenue model is bolstered by its ability to innovate and adapt to customer needs, maintaining strong relationships with key clients and investing in research and development to create new products and improve existing ones.

Nolato AB Financial Statement Overview

Summary

Nolato AB exhibits robust financial health with impressive revenue growth, strong profitability metrics, a debt-free balance sheet, and excellent cash flow generation. The high equity ratio and return on equity further reinforce its financial stability and operational efficiency.

Income Statement

Nolato AB has shown impressive revenue growth from 2023 to 2024, with a positive trajectory in gross profit and net income, reflecting strong operational performance. The gross profit margin improved to 16.69%, and the net profit margin increased to 6.81%, indicating enhanced profitability. EBIT and EBITDA margins also indicate robust operating efficiency. Overall, the company demonstrates solid revenue growth and profitability metrics, with room for further margin improvements.

Balance Sheet

The balance sheet of Nolato AB is strong, with a debt-free position contributing to stability. The equity ratio is high at 59.23%, indicating significant financial stability and low leverage risk. Return on equity has improved to 11.47%, showcasing efficient use of shareholder capital. The company has effectively managed its liabilities, reducing total debt to zero, thus minimizing financial risk.

Cash Flow

Cash flow analysis reveals excellent performance with significant free cash flow growth and strong operating cash flow. The free cash flow growth rate was substantial, and the operating cash flow to net income ratio of 2.09 indicates excellent cash generation relative to net income. The company's ability to generate free cash flow supports future investment opportunities and financial flexibility.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	9.68B	9.66B	9.55B	10.77B	11.61B	9.36B
Gross Profit	1.66B	1.61B	1.34B	1.43B	1.82B	1.51B
EBITDA	1.40B	1.52B	1.28B	1.48B	1.92B	1.46B
Net Income	695.00M	658.00M	435.00M	697.00M	1.16B	806.00M
Balance Sheet
Total Assets	9.41B	9.69B	9.30B	10.01B	10.05B	8.68B
Cash, Cash Equivalents and Short-Term Investments	568.00M	672.00M	688.00M	1.01B	1.45B	1.49B
Total Debt	1.52B	1.53B	1.88B	1.93B	1.62B	1.88B
Total Liabilities	3.85B	3.95B	4.13B	4.62B	5.29B	4.99B
Stockholders Equity	5.56B	5.74B	5.17B	5.39B	4.77B	3.70B
Cash Flow
Free Cash Flow	1.38B	742.00M	351.00M	-49.00M	446.00M	791.00M
Operating Cash Flow	1.38B	1.38B	781.00M	406.00M	1.23B	1.16B
Investing Cash Flow	-677.00M	-636.00M	-444.00M	-451.00M	-782.00M	-1.70B
Financing Cash Flow	-764.00M	-798.00M	-631.00M	-487.00M	-634.00M	730.00M

Nolato AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 56.60
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NOLA.B, the sentiment is Negative. The current price of 56.6 is below the 20-day moving average (MA) of 58.50, below the 50-day MA of 58.16, and above the 200-day MA of 55.92, indicating a neutral trend. The MACD of -0.41 indicates Positive momentum. The RSI at 39.49 is Neutral, neither overbought nor oversold. The STOCH value of 36.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:NOLA.B.

Nolato AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NOLA.B	71 Outperform	$15.49B	20.99	13.55%	2.65%	1.67%	55.37%
Sector *	64 Neutral	CHF26.60B	17.29	9.71%	2.35%	21.08%	2.84%
0O5H	―	kr18.17B	76.70	2.43%	―	―	―
0YAY	―	kr18.15B	40.00	3.46%	5.56%	―	―
ADDLF	―	$2.09B	63.90	6.27%	0.21%	―	―
61MA	―	€892.64M	49.93	15.85%	―	―	―
0V0	―	€1.49B	64.38	3.34%	―	―	―

Nolato AB Corporate Events

Nolato AB Reports Strong Q2 2025 Results and Strategic Expansion Plans

Nolato AB reported a strong second quarter in 2025, with organic growth reaching 4% and an EBITA margin increase to 11.6%. The company is making strategic investments for future growth, particularly in its Medical Solutions and Engineered Solutions business areas, despite challenges in the automotive market. The expansion in Malaysia aims to strengthen Nolato’s position in Asia and improve production capabilities globally. The company remains optimistic about the rest of the year, supported by a robust financial position and strategic geographical presence.

Nolato AB to Release Q2 2025 Interim Report and Host Webcast

Nolato AB announced it will release its interim report for the second quarter of 2025 on July 18, followed by a webcast conference call. This event will feature presentations by the company’s President and CEO, Christer Wahlquist, and CFO, Per-Ola Holmström, providing insights into the company’s performance and addressing questions from stakeholders.